Comments
Drugmakers Lilly, Bristol weather patent cliffs
26.07.2012. | (Reuters) - Eli Lilly and Co beat profit forecasts and vowed to bounce back by 2015 from its steep patent cliff due to cost cutting and new medicines, while rival U.S. drugmaker Bristol-Myers signaled it is weathering its own painful patent expirations as well as expected....
